首页> 美国卫生研究院文献>Molecular Genetics Genomic Medicine >PTBP1 acts as a dominant repressor of the aberrant tissue‐specific splicing of ISCU in hereditary myopathy with lactic acidosis
【2h】

PTBP1 acts as a dominant repressor of the aberrant tissue‐specific splicing of ISCU in hereditary myopathy with lactic acidosis

机译:PTBP1作为遗传性肌病伴乳酸性酸中毒的ISCU异常组织特异性剪接的主要抑制因子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHereditary myopathy with lactic acidosis (HML) is an autosomal recessive disease caused by an intron mutation in the iron‐sulfur cluster assembly (ISCU) gene. The mutation results in aberrant splicing, where part of the intron is retained in the final mRNA transcript, giving rise to a truncated nonfunctional ISCU protein. Using an ISCU mini‐gene system, we have previously shown that PTBP1 can act as a repressor of the mis‐splicing of ISCU, where overexpression of PTBP1 resulted in a decrease of the incorrect splicing. In this study, we wanted to, in more detail, analyze the role of PTBP1 in the regulation of endogenous ISCU mis‐splicing.
机译:背景患有乳酸性酸中毒(HML)的遗传性肌病是一种常染色体隐性疾病,由铁硫簇装配(ISCU)基因的内含子突变引起。突变导致异常剪接,其中部分内含子保留在最终的mRNA转录物中,从而导致截短的无功能ISCU蛋白。使用ISCU微型基因系统,我们以前已经证明PTBP1可以作为ISCU错接的阻遏物,其中PTBP1的过表达导致不正确剪接的减少。在这项研究中,我们想更详细地分析PTBP1在调节内源性ISCU错接中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号